NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program
Next-generation sequencing (NGS) is being integrated into routine clinical practice in the field of (hemato-) oncology to search for variants with diagnostic, prognostic, or therapeutic value at potentially low allelic frequencies. The complex sequencing workflows used require careful validation and...
Main Authors: | Thomas Delcourt, Kevin Vanneste, Mohamed Rida Soumali, Wim Coucke, Vanessa Ghislain, Aline Hebrant, Els Van Valckenborgh, Sigrid C. J. De Keersmaecker, Nancy H. Roosens, Philippe Van De Walle, Marc Van Den Bulcke, Aline Antoniou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3180 |
Similar Items
-
Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
by: Kristýna Hricová, et al.
Published: (2020-11-01) -
Orofacial manifestation of hematological disorders: Hemato-oncologic and immuno-deficiency disorders
by: Titilope A Adeyemo, et al.
Published: (2011-01-01) -
Exploring Psychological Needs and Burden of Care in Parents of Children with Hemato-Oncological Diseases
by: Loredana Benedetto, et al.
Published: (2022-08-01) -
Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
by: Aksak-Wąs BJ, et al.
Published: (2022-08-01) -
Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease
by: Lee HJ, et al.
Published: (2015-12-01)